Other News

Neovasc Reducer Featured in Live Case at ICI 2017

VANCOUVER, Dec. 6, 2017 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX: NVCN) today reported its Neovasc Reducer™ (“Reducer”) medical device was featured in a “live case” broadcast at the 2017 Innovations in Cardiovascular Interventions (ICI) conference held in Tel Aviv, Israel.  In the live case broadcast to the conference from […]

InspireMD Announces Expansion of its Distribution Network for CGuard™ EPS in Australia, New Zealand and Vietnam

TEL AVIV, lSRAEL, Dec. 04, 2017 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed Diverse Devices Pty Ltd as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production […]

CorInnova Awarded “2017 InnoSTARS” Prize for Its Non-Blood-Contacting, Soft Robotic Heart Assist Device as Alternative to LVADs for Treatment of Heart Failure

By Ronald Trahan, APR, Ronald Trahan Associates, 1-508-816-6730, rtrahan@ronaldtrahan.com HOUSTON, Dec. 4, 2017—CorInnova Inc., an emerging medical device company developing novel technology for the treatment of Heart Failure, announced today that it was awarded second prize in the “2017 InnoSTARS” life science competition for its EpicHeart™ soft-robotic heart assist device. […]

FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke

THOUSAND OAKS, Calif., Dec. 1, 2017 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha® (evolocumab) as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease.1 “We are pleased […]

Corindus Partners With Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center, a leading cardiovascular center located in the Texas Medical Center, has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX […]

CryoLife Completes Acquisition of JOTEC

ATLANTA, Dec. 1, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of JOTEC AG, a German-based, privately-held developer of technologically differentiated endovascular stent grafts, and cardiac and vascular surgical […]

BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) — BioTelemetry(NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple(NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.  […]

Updated TCAR Data From Silk Road Medical’s ROADSTER 1 and 2 Studies Presented at VEITHsymposium

SUNNYVALE, Calif., Nov. 29, 2017 /PRNewswire/ — Silk Road Medical, a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced multiple presentations at the 45th annual VEITHsymposium highlighting the safety and efficacy of the company’s ENROUTE® Transcarotid Neuroprotection and Stent System, the first and only products specifically designed and […]